These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 21962963

  • 21. Increased fibre and reduced trans fatty acid intake are primary predictors of metabolic improvement in overweight polycystic ovary syndrome-Substudy of randomized trial between diet, exercise and diet plus exercise for weight control.
    Nybacka Å, Hellström PM, Hirschberg AL.
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):680-688. PubMed ID: 28727165
    [Abstract] [Full Text] [Related]

  • 22. [Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition].
    Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U.
    Minerva Ginecol; 2012 Feb; 64(1):23-9. PubMed ID: 22334228
    [Abstract] [Full Text] [Related]

  • 23. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
    Scott D, Harrison CL, Hutchison S, de Courten B, Stepto NK.
    PLoS One; 2017 Feb; 12(8):e0182412. PubMed ID: 28771628
    [Abstract] [Full Text] [Related]

  • 24. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome.
    Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS.
    Fertil Steril; 2004 Mar; 81(3):630-7. PubMed ID: 15037413
    [Abstract] [Full Text] [Related]

  • 25. Endometrial Expression of Estrogen Receptors and the Androgen Receptor in Women With Polycystic Ovary Syndrome: A Lifestyle Intervention Study.
    Hulchiy M, Nybacka Å, Sahlin L, Hirschberg AL.
    J Clin Endocrinol Metab; 2016 Feb; 101(2):561-71. PubMed ID: 26649621
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [Abstract] [Full Text] [Related]

  • 27. Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome.
    Roessler KK, Birkebaek C, Ravn P, Andersen MS, Glintborg D.
    Acta Obstet Gynecol Scand; 2013 Mar; 92(3):272-7. PubMed ID: 23237575
    [Abstract] [Full Text] [Related]

  • 28. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
    Jiskoot G, Benneheij SH, Beerthuizen A, de Niet JE, de Klerk C, Timman R, Busschbach JJ, Laven JS.
    Reprod Health; 2017 Mar 06; 14(1):34. PubMed ID: 28264692
    [Abstract] [Full Text] [Related]

  • 29. Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women.
    Orio F, Giallauria F, Palomba S, Manguso F, Orio M, Tafuri D, Lombardi G, Carmina E, Colao A, Vigorito C.
    Clin Endocrinol (Oxf); 2008 Jun 06; 68(6):976-81. PubMed ID: 17980005
    [Abstract] [Full Text] [Related]

  • 30. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
    Jedel E, Labrie F, Odén A, Holm G, Nilsson L, Janson PO, Lind AK, Ohlsson C, Stener-Victorin E.
    Am J Physiol Endocrinol Metab; 2011 Jan 06; 300(1):E37-45. PubMed ID: 20943753
    [Abstract] [Full Text] [Related]

  • 31. Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.
    Turner-McGrievy G, Davidson CR, Billings DL.
    Hum Fertil (Camb); 2015 Mar 06; 18(1):16-21. PubMed ID: 24921163
    [Abstract] [Full Text] [Related]

  • 32. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
    Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ.
    Fertil Steril; 2009 Dec 06; 92(6):1966-82. PubMed ID: 19062007
    [Abstract] [Full Text] [Related]

  • 33. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
    Nafiye Y, Sevtap K, Muammer D, Emre O, Senol K, Leyla M.
    Fertil Steril; 2010 Apr 06; 93(6):1864-9. PubMed ID: 19171332
    [Abstract] [Full Text] [Related]

  • 34. Obesity and lifestyle management in polycystic ovary syndrome.
    Hoeger KM.
    Clin Obstet Gynecol; 2007 Mar 06; 50(1):277-94. PubMed ID: 17304042
    [Abstract] [Full Text] [Related]

  • 35. Effects of protein versus simple sugar intake on weight loss in polycystic ovary syndrome (according to the National Institutes of Health criteria).
    Kasim-Karakas SE, Almario RU, Cunningham W.
    Fertil Steril; 2009 Jul 06; 92(1):262-70. PubMed ID: 18691705
    [Abstract] [Full Text] [Related]

  • 36. Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome.
    Ornstein RM, Copperman NM, Jacobson MS.
    J Pediatr Adolesc Gynecol; 2011 Jun 06; 24(3):161-5. PubMed ID: 21419674
    [Abstract] [Full Text] [Related]

  • 37. Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.
    Ravn P, Haugen AG, Glintborg D.
    Minerva Endocrinol; 2013 Mar 06; 38(1):59-76. PubMed ID: 23435443
    [Abstract] [Full Text] [Related]

  • 38. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
    Bizzarri C, Benevento D, Ravà L, Patera IP, Schiaffini R, Ciampalini P, Giannone G, Cappa M.
    Fertil Steril; 2011 Dec 06; 96(6):1497-1502.e1. PubMed ID: 21982726
    [Abstract] [Full Text] [Related]

  • 39. Lifestyle modification intervention among infertile overweight and obese women with polycystic ovary syndrome.
    Mahoney D.
    J Am Assoc Nurse Pract; 2014 Jun 06; 26(6):301-8. PubMed ID: 24170708
    [Abstract] [Full Text] [Related]

  • 40. An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome.
    Karimzadeh MA, Javedani M.
    Fertil Steril; 2010 Jun 06; 94(1):216-20. PubMed ID: 19463994
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.